Researchers, led by Dr. Bing Wang, Professor in the Department of General Surgery at Shanghai Ninth People's Hospital and Shanghai Jiao Tong University School of Medicine in Shanghai, China, are utilizing mesenchymal stem cells (MSCs) to treat obesity and type II diabetes, two of the most significant healthcare concerns for adults worldwide. This study explored the use of MSCs (the same type of stem cells found in teeth) to treat the inflammation due to obesity that often causes or exacerbates the insulin resistance in type II diabetes. In an animal model, the stem cells were used to to restore metabolic balance and mitigate insulin resistance that arises when high blood glucose levels persist for extended periods of time. The stem cells, known for their anti-inflammatory properties, also expressed a growth factor called neuregulin 4, which is known to effectively combat the effects of obesity.
Since many of the long-term effects of obesity can cause chronic health issues, studies addressing obesity and Type II diabetes are becoming increasingly important. With more people living sedentary lifestyles and consuming high-sugar diets, these health concerns affect other organ systems and contribute to a variety of consequent afflictions that arise when obesity and type II diabetes go unchecked.
To learn more about stem cells, and how families can bank their own valuable stem cells by recovering the very powerful dental pulp stem cells during routine dental procedures; such as wisdom teeth extractions or the during the loss of baby teeth, visit StemSave or call 877-783-6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.